Global Organ Preservation Market Size, Share, Growth Analysis, By Solutions(UW, Custodial HTK), By Technique(Static Cold Storage, Hypothermic), By Organ(Kidneys, Liver), By End User(Transplant Centers, Hospitals) - Industry Forecast 2022-2028

Global organ preservation market is segmented based on the product, end user, and region. Based on the solution, the global organ preservation market is segmented into UW, custodial HTK, and perfadex. Based on technique the global organ preservation market is segmented into static cold storage, hypothermic, and normothermic. Based on the organ, the global organ preservation market is segmented into kidneys, liver, and heart. Based on end-user, the global organ preservation market is segmented into transplant centers, hospitals, and specialty clinics. Based on region, it is categorized into North America, Europe, Asia-Pacific, Latin America, and MEA.

Analysis by Solution

The University of Wisconsin (UW) had the greatest share in 2021 as a result of the solution's increased utilization and several benefits. In comparison to previous treatments, the solution enables the preservation of human liver transplants for a period of time greater than 15 hours. Additionally, it makes it simple to transfer organs safely across long distances. It primarily aids in liver preservation and raises the success percentage of liver transplantation. It is projected that rising liver transplantation rates would fuel market expansion.

Over the projection period, the perfadex category is predicted to see the quickest CAGR. This treatment is designed primarily to protect the integrity and functionality of endothelium-rich organs during cold ischemia storage and flushing prior to reperfusion and transplantation. Although it is primarily utilised to protect the lungs, this solution can also be used to save other organs. Therefore, it is projected that these benefits would encourage segment expansion over the projection period.

Analysis by Organ

In 2021, the kidney market category had the biggest market share. The main factors impacting the market growth are the rising number of renal failure sufferers and kidney transplant surgeries worldwide. In the United States, around 37.00 million people have chronic kidney disease, and nearly 726,000 people per year have end-stage renal disease, according to a report released by the NHS in 2020. It is also projected that various kidney transplant awareness campaigns would aid in segment expansion. For instance, the NHS started the "Advancing American Kidney Health" Initiative with the goal of bettering the lives of kidney disease patients in the United States.

Over the projection period, the heart category is predicted to see the quickest CAGR. Over the projection period, the segment's growth is anticipated to be driven by the increasing number of heart transplant operations. According to a study released by the Health Resources & Services Administration, about 3,408 heart transplant surgeries were carried out in 2020, compared to around 3,273 treatments carried out in the U.S. in 2017. In the upcoming years, it is projected that this tendency will fuel the segment's expansion.

Analysis by Technique

As a result of its broad application and rising utilisation, the static cold storage market had the biggest share in 2019. Kidney preservation makes extensive use of static cold storage. The preservation of other organs is also done with it, though. The expansion of the category is also projected to be aided by the existence of several market participants that offer static cold storage.

Over the projected period, the normothermic machine perfusion segment is predicted to see the quickest CAGR. With this method, the organ receives enough nourishment and oxygen to support aerobic metabolism. Additionally, it lowers the possibility of post-transplant adverse effects and contributes to better transplant results. Although it is primarily used to save the liver, it also effectively preserves other organs. Therefore, throughout the course of the projected period, these benefits are anticipated to foster market expansion.

In 2021, North America accounted for the biggest market share, and it is anticipated that it will continue to dominate over the projected period. The main drivers of growth are the increasing adoption of cutting-edge healthcare technology, the high prevalence of chronic renal disease and heart failure, improved reimbursement rules, and rising investments in expanding healthcare infrastructure. The regional market is also anticipated to rise as a result of the ageing population and an increase in organ transplant surgeries.

Due to rising healthcare costs, patient awareness, and a growing demand for organ transplant operations, Asia Pacific is expected to see the fastest increase throughout the projection period. In the years to come, it is also projected that the ageing population, increased rates of renal and heart failure, and rising healthcare costs would all contribute to the market's expansion.

Driver

• One of the most frequent causes of mortality in ICUs is multiple organ failure, which is mostly brought on by sepsis. According to estimates, up to 20% of individuals with sepsis exhibit acute respiratory failure and 26–50% develop acute renal failure (Society of Critical Care Medicine). Acute renal failure is more common in the elderly due to age-related declines in renal plasma flow and glomerular filtration rate. Diabetes makes people more susceptible to both of these diseases and multiple organ failure. Geriatric patients are more likely to have illnesses including TB and liver cirrhosis, which may necessitate organ transplantation.
• The proportion of elderly persons undergoing organ transplants has increased, which has a significant influence on the number of organ transplantation procedures performed, according to the Organ Procurement and Transplantation Network. For instance, the number of organ transplants in the over-65 age category increased in the US from 8,691 in 2019 to 8,895 in 2021. According to the UN World Population Ageing Report, there were 728 million individuals in the world who were 65 or older in 2020; this number is predicted to reach 1.5 billion by 2050, indicating the possibility of rising demand. Due to this demographic segment's high sensitivity to illnesses that cause organ failure, its increase will be a significant factor in the market's expansion.

Restraint

• Organ transplantation requires a lot of resources, including highly compensated doctors and surgeons, pricy transportation, and expensive medications. The whole cost is increased by the fees for inpatient treatment, organ procurement, preservation, post-operative recipient care, and anti-rejection drugs. For assessment or follow-up appointments arranged at the transplant centre for a recommended length of medical care, patients must additionally pay additional expenses for travel, housing, meals, hospital visits, and other medical tests.

The global organ preservation market is relatively fragmented, with a high level of competition. The prominent players operating in the market are constantly adopting various growth strategies to stay afloat in the market. Product launches, innovations, mergers, and acquisitions, collaborations and partnerships, and intensive R&D are some of the growth strategies that are adopted by these key players to thrive in the competitive market. The key market players are also constantly focused on R&D to supply industries with the most efficient and cost-effective solutions.

Top Player in the Global Organ Preservation Market

• Paragonix Technologies (US)
• XVIVO Perfusion AB (Sweden)
• Dr. Franz Köhler Chemie GmbH (Germany)
• Essential Pharmaceuticals LLC (US)
• Trans Medics (US)
• Organ Ox Limited (UK)
• 21st Century Medicine (US)
• Shanghai Genext Medical Technology (China)
• Bridge to Life Limited (US)
• Waters Medical Systems (US)
• Preservation Solutions (US)
• Carnamedica (Poland)

Recent Developments

• In August 2021, he LIVERguard Donor Liver Preservation System was introduced by Paragonix Technologies in the US and Europe. This tactic boosted Paragonix's global footprint and broadened their range of products.
• In June 2021, in order to grow its company and have access to a wide network of transplantation clinics in Brazil, the biggest nation in Latin America, XVIVO Perfusion teamed with Contatti Medical (Brazil.

• To provide better healthcare services, governments all around the world are concentrating on bolstering their healthcare infrastructures. For instance, the Brihanmumbai Municipal Corporation in India set aside around USD 924 million (INR 7,000 crore), or 15% of its budget for 2022–2023, to improve health services and create 100 health clinics with more than 100 diagnostic tests for preventative and primary treatment in BMC regions. There will be more hospitals that handle more brain-dead people who could make good donors as a result of these infrastructure upgrades. The time involved with donor-recipient cross-matching, subject profiling, genotyping, and other associated diagnostic tests during the pre-transplantation phase will also be improved by the growth in testing labs. It is anticipated that these discoveries would open up new potential for the organ preservation sector.

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected utilizing Primary Exploratory Research backed by the robust Secondary Desk research.

According to our global organ preservation market analysis, in terms of solution, the UW segment held the largest share in the market as it makes it simple to transfer organs safely across long distances. It primarily aids in liver preservation and raises the success percentage of liver transplantation. By organ the kidney segment held the largest share in the market, the main factors impacting the market growth are the rising number of renal failure sufferers and kidney transplant surgeries worldwide. And by region, North America accounted for the biggest market share, and it is anticipated that it will continue to dominate over the projected period. The main drivers of growth are the increasing adoption of cutting-edge healthcare technology, the high prevalence of chronic renal disease and heart failure, improved reimbursement rules, and rising investments in expanding healthcare infrastructure.